Tennor Therapeutics
PrivateLast Round
Series D
May 26, 2026
Total Funding Raised
$96.19M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tennor Therapeutics is a biotechnology research company that discovers and develops novel multi-functional drugs for the treatment of cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tennor Therapeutics Comparables
Compare Tennor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gurnet Point Capital | 75% | |
| RedHill Biopharma | 73% | |
| Trellis Bioscience | 68% |
Tennor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 26, 2026 | ||||
| Series E | Oct 16, 2024 | ||||
| Series D Extension | Jan 5, 2023 | ||||
| Series D | Feb 25, 2022 | ||||
| Series C Extension | Jun 5, 2020 | ||||
Series C | Sep 19, 2016 |
Tennor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 中山创业投资有限公司 | Series E |
| AMR Action Fund | Series E |
| Yuanjing Investment | Series D Extension |
| Yanchuang Capital | Series D |
| Oriza Holdings | Series C Extension, Series B, Series D |
| Al Mal Investment Company | Series B |
| Northern Light Venture Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$15M raised in Seed Round.
- Oct 16, 2024
Raised $42.4M led by 中山创业投资有限公司
Tennor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tennor Therapeutics's valuation, stock price, and market status.
Is Tennor Therapeutics a public or private company?
Tennor Therapeutics is a private company.
What is the current stock price of Tennor Therapeutics?
Tennor Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tennor Therapeutics worth (valuation)?
Valuation information for Tennor Therapeutics is not publicly available.
Can I buy Tennor Therapeutics stock?
Tennor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tennor Therapeutics's last funding round?
Tennor Therapeutics's most recent funding round was Series D on May 26, 2026.
Who are the main investors in Tennor Therapeutics?
Key investors in Tennor Therapeutics include 中山创业投资有限公司, Yanchuang Capital, Northern Light Venture Capital.
Will Tennor Therapeutics IPO soon?
No public IPO plans have been announced for Tennor Therapeutics.
How can I track Tennor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tennor Therapeutics's secondary market activity and sign up for updates.